ExpreS2ion Biotech
ExpreS2ion to Participate in Key Investor Event in January 2026
These events represent important opportunities to showcase ExpreS2ion’s innovative technology platform and exciting development pipeline to scientific and investment audiences. More details, including event registration information, are available on the Company’s website and via the links below. To arrange a meeting at these events, please contact us at partnering@expres2ionbio.com or investor@expres2ionbio.com.
21 January 2026 | Redeye Theme: Fight Cancer
Stockholm, Sweden and virtual
ExpreS2ion will participate in Redeye Theme: Fight Cancer 2026, a focused life sciences investor event highlighting Nordic companies active in oncology and cancer-related innovation. CFO Keith Alexander will present ExpreS2ion at 10:50 CET, sharing updates on the company’s cancer vaccine programs and strategic priorities. For more details about the event, including how participate in person or stream the presentation, see the official event page.
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
| Datum | 2026-01-19, kl 10:26 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!